Please login to the form below

Not currently logged in
Email:
Password:

Horizon Discovery

This page shows the latest Horizon Discovery news and features for those working in and with pharma, biotech and healthcare.

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

Abcam launches takeover for gene-editing specialists Horizon Discovery. Abcam, a UK-based biotech research services firm launched a takeover bid for its neighbour and rival Horizon Discovery this week, but ... Horizon Discovery released a statement on

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare

    direct a team of around 150 scientists at the MSD UK Discovery Centre. ... In addition, she is a Non-Executive Director on the Board of Cambridge-based Horizon Discovery.

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    Other deals include an alliance with the UK biotech Immunocore via AZ's MedImmune subsidiary and an expansion of an existing personalised drug partnership with Horizon Discovery. “ ... Drug discovery and development is a team sport. You can't do it

  • Deal Watch table for April 2013 Deal Watch table for April 2013

    392. Ambrx/ Astellas Pharma. Collaboration. Oncology discovery and development of novel antibody drug conjugates. ... 100. Horizon Discovery/ AstraZeneca. Collaboration. Kinase target programme, HD-001, as a means of developing novel therapies for

  • Pharma deals during April 2013 Pharma deals during April 2013

    This will enable the discovery of novel small molecules against multiple AZ targets in oncology, respiratory, cardiovascular, metabolism, infection and neuroscience. ... The third April “ top 20” AZ deal is a collaboration with Horizon Discovery to

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Eric Rhodes becomes CEO of ERS Genomics Eric Rhodes becomes CEO of ERS Genomics

    Rhodes joins ERS Genomics from Horizon Discovery, where he served as senior vice president of research and development and chief technology officer. ... Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of

  • Jane Osbourn to chair BIA board Jane Osbourn to chair BIA board

    The new members of the board are Darrin Disley, chief executive of Horizon Discovery Group and David Hipkiss, chief business officer at Circassia Pharmaceuticals.

  • Horizon Discovery appoints executive director Horizon Discovery appoints executive director

    Horizon Discovery appoints executive director. David Smoller is chief business officer at the genomics firm. ... UK-based genetic research company Horizon Discovery has named Dr David Smoller as an executive director of the board.

  • Horizon adds AZ’s Galbraith to board Horizon adds AZ’s Galbraith to board

    Horizon adds AZ’ s Galbraith to board. UK genomics company also appoints Susan Searle. ... Horizon Discovery has appointed two new board members, AstraZeneca's head of oncology R&D Susan Galbraith and Susan Searle, ex-CEO of Imperial Innovations Group.

  • Horizon appoints board chair Horizon appoints board chair

    Horizon appoints board chair. Dr Ian Gilham assumes position full-time. Horizon Discovery has appointed Dr Ian Gilham as chairman of its board of directors on a permanent basis after he ... from his guidance as Horizon continues to develop as a

More from appointments
Approximately 3 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics